Meaningful Use Stage 2 product, OneView 4.0 now certified for all Clinical Quality Measures

Acmeware goes live with Beta installations of OneView 4.0 for EHR Meaningful Use.
By: Acmeware, Inc.
DEDHAM, Mass. - Jan. 10, 2014 - PRLog -- Acmeware, a leading provider of business intelligence using the MEDITECH Data Repository, today announced that its Meaningful Use product, OneView 4.0, has enhanced its ONC-certified EHR module by certifying for 13 additional Clinical Quality Measures of the 2014 Edition’s criteria: CMS9, CMS26, CMS30, CMS31, CMS53, CMS60, CMS100, CMS113, CMS171, CMS172, CMS178, CMS185 & CMS188. The certification affirms that OneView 4.0 provides the capabilities, functionalities and security necessary for healthcare organizations to meet the requirements for both Stage 1 and Stage 2 Meaningful Use. Acmeware has the most complete set of Meaningful Use Criteria for a MEDITECH vendor.

Acmeware is helping MEDITECH hospitals prepare for their FY14 attestations by immediately releasing our certified 2014 Edition EHR Meaningful Use reporting application OneView 4.0 to beta sites. “Providing our clients with early access to their 2014 (Stage 1 or Stage 2) EHR performance measures offers them time to implement necessary changes in business practices to address any performance shortcomings” says Glen D’Abate, President of Acmeware. Moreover, Acmeware’s Bottom Up BI™ approach allows for rapid development of custom meaningful use analysis and validation reports to further identify opportunities for improved performance.

Acmeware’s  OneView 4.0 is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of the U.S. Department of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments."

Acmeware, Inc., Modular EHR Inpatient, Certified 9/26/2013, Certificate No. 09262013‐2128‐9OneView 4.0, Modules Tested: 170.314(c)(1, 2, 3); 170.314(d)(1, 2, 3, 5, 6, 7, 8); 170.314(g)(2, 4). Clinical Quality Measures tested: CMS009v2; CMS026v1; CMS030v3; CMS031v2; CMS032v3; CMS053v2; CMS055v2; CMS060v2; CMS071v3; CMS072v2; CMS073v2; CMS091v3; CMS100v2; CMS102v2: CMS104v2; CMS105v2; CMS107v2; CMS108v2; CMS109v2; CMS110v2; CMS111v2; CMS113v2; CMS114v2; CMS171v3; CMS172v3; CMS178v3; CMS185v2; CMS188v3; CMS190v2. Additional software used: MS SQL Server

Pricing Transparency

OneView 4.0 requires a one-time cost, plus annual maintenance service fee for the included software:

OneView EHR Meaningful Use Package

In addition to OneView version 4.0, other vendor licensing fees are needed.

Microsoft SQL Server relational database license

About Acmeware, Inc.

Acmeware, Inc. provides consulting services, training, products, and custom software solutions that assist clients in realizing the maximum benefit from their MEDITECH Data Repository (DR) application. We are a service-oriented company working in partnership with our DR clients to leverage the latest technologies, transform disparate raw data to knowledge, and deliver valuable insight to healthcare organizations. Acmeware's dedicated focus on DR related services allows us to provide solutions that are innovative, efficient, accurate, and affordable.

Acmeware, Inc.
Email:*** Email Verified
Tags:Meaningful Use, Meditech, Healthcare Data, EHR Meaningful Use, CMS Incentive
Industry:Health, Technology
Location:Dedham - Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Page Updated Last on: Jan 10, 2014
Acmeware News
Most Viewed
Daily News

Like PRLog?
Click to Share